

Developing medicines that are delivered via the pulmonary and nasal routes for the treatment of local and systemic diseases is challenging. While the demonstration of safety, potency and purity is a fundamental part of the marketing authorization process for all drugs, incorporation of a delivery device greatly increases the complexity of the drug development process.
PPD™ Laboratory services GMP lab has been supporting the respiratory community across the product development continuum for more than 17 years. We have depth of experience evaluating drug/device combinations and have authored several publications and presentations on the topic. Our scientists have chosen a few of their presentations and publications to share with you.